Comments Off on Building Bold Companies
Comments Off on Alumis soars as TYK2 drug hits mark in psoriasis trials
Comments Off on Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell
Comments Off on How AI Will Transform Drug Discovery with Foresite Labs CEO Vik Bajaj
Comments Off on Q&A: Project Stargate and the viability of AI cancer vaccines
Comments Off on AI-based predictive biology coming soon, Foresite’s Bajaj says
Comments Off on Grail and Verily Alum on Billion Dollar Startup Bringing AI to Drug Development: A Discussion with Vik Bajaj
Comments Off on The Nobel Prize in Chemistry
Comments Off on Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers
Comments Off on LinkedIn Top Startups 2024: The 50 U.S. companies on the rise
